Hisham Abdel Azim
Pediatric Hematology-Oncology · Los Angeles, CANPI 1114018694
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $43,581 of the $52,037 with a category attached, or 83.8%. 13 manufacturers reported payments, led by Vertex at 27.0% of the total. 2025 is the largest year on record at $24,733, more than ten times the $1,045 reported in 2021. Among pediatric hematology-oncology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 68 payments — averaging $765.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertex$14K
- Gilead$13K
- Adaptive Biotechnologies Corporation$13K
- Novartis$8K
- Janssen Scientific Affairs, LLC$1K
- Jazz Pharmaceuticals Inc.$881
- plus $1K from 7 others
Across 929 payments — averaging $1342.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Adaptive Biotechnologies Corporation$1.2M
- Merck$32K
- Mallinckrodt Enterprises LLC$14K
- National Marrow Donor Program$8K
- Mallinckrodt Hospital Products Inc.$8K
- Bristol Myers Squibb$5K
- plus $5K from 1 others
What the payments were for
- Consulting fees$43,58184%
- Travel & lodging$4,4259%
- Food & beverage$4,0308%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertex | 18 | $14,040 |
| Gilead | 14 | $13,489 |
| Adaptive Biotechnologies Corporation | 12 | $12,993 |
| Novartis | 7 | $8,225 |
| Janssen Scientific Affairs, LLC | 1 | $1,226 |
| Jazz Pharmaceuticals Inc. | 7 | $881 |
| Mesoblast, Inc. | 2 | $252 |
| National Marrow Donor Program | 1 | $215 |
| Genetix Biotherapeutics Inc | 2 | $194 |
| Janssen Research & Development, LLC | 1 | $146 |
| Medexus Pharma, Inc. | 1 | $127 |
| Blueprint Medicines Corporation | 1 | $125 |
| Sobi, Inc | 1 | $123 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$52,037 in reported general payments places this provider in the 90th percentile of 307 pediatric hematology-oncology providers in California.
See all pediatric hematology-oncology providers in California →
Other pediatric hematology-oncology in Los Angeles
- Noah FedermanLos Angeles$399K
- Jan van TornoutLos Angeles$137K
- Thomas CoatesLos Angeles$99K
- Andrew DietzLos Angeles$88K
- Geetha PuthenveetilLos Angeles$62K
- Michael PulsipherLos Angeles$45K
- Leo MascarenhasLos Angeles$35K
- Edward GompertsLos Angeles$28K
- Paibel Aguayo-HiraldoLos Angeles$21K
- Paul GaynonLos Angeles$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.